Juan C. Jaen, the President of $RCUS, sold 29,365 shares of the company on 10-29-2025 for an estimated $632,166. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.6% of their shares of this class of stock. Following this trade, they now own 1,092,174 shares of this class of $RCUS stock.
$RCUS Insider Trading Activity
$RCUS insiders have traded $RCUS stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $RCUS stock by insiders over the last 6 months:
- JUAN C. JAEN (President) has made 0 purchases and 4 sales selling 96,859 shares for an estimated $2,010,578.
- JENNIFER JARRETT (Chief Operating Officer) has made 0 purchases and 2 sales selling 50,292 shares for an estimated $750,412.
- II ROBERT C. GOELTZ (Chief Financial Officer) sold 5,000 shares for an estimated $100,000
- ALEXANDER AZOY (Chief Accounting Officer) has made 0 purchases and 2 sales selling 4,410 shares for an estimated $55,561.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RCUS Hedge Fund Activity
We have seen 105 institutional investors add shares of $RCUS stock to their portfolio, and 79 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. added 3,099,567 shares (+108.1%) to their portfolio in Q2 2025, for an estimated $25,230,475
- FMR LLC removed 1,883,552 shares (-42.3%) from their portfolio in Q2 2025, for an estimated $15,332,113
- SUVRETTA CAPITAL MANAGEMENT, LLC added 1,127,954 shares (+44.0%) to their portfolio in Q2 2025, for an estimated $9,181,545
- WOODLINE PARTNERS LP removed 1,127,275 shares (-22.0%) from their portfolio in Q2 2025, for an estimated $9,176,018
- MORGAN STANLEY added 682,724 shares (+86.7%) to their portfolio in Q2 2025, for an estimated $5,557,373
- DECHENG CAPITAL LLC removed 648,789 shares (-80.2%) from their portfolio in Q2 2025, for an estimated $5,281,142
- PARKMAN HEALTHCARE PARTNERS LLC removed 616,019 shares (-50.7%) from their portfolio in Q2 2025, for an estimated $5,014,394
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RCUS Analyst Ratings
Wall Street analysts have issued reports on $RCUS in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 10/29/2025
- Citigroup issued a "Buy" rating on 10/29/2025
- Wells Fargo issued a "Overweight" rating on 10/20/2025
- Morgan Stanley issued a "Overweight" rating on 05/09/2025
To track analyst ratings and price targets for $RCUS, check out Quiver Quantitative's $RCUS forecast page.
$RCUS Price Targets
Multiple analysts have issued price targets for $RCUS recently. We have seen 6 analysts offer price targets for $RCUS in the last 6 months, with a median target of $28.5.
Here are some recent targets:
- Emily Bodnar from HC Wainwright & Co. set a target price of $28.0 on 10/29/2025
- Yigal Nochomovitz from Citigroup set a target price of $56.0 on 10/29/2025
- Eva Fortea Verdejo from Wells Fargo set a target price of $29.0 on 10/20/2025
- Asthika Goonewardene from Truist Securities set a target price of $39.0 on 10/07/2025
- Terence Flynn from Morgan Stanley set a target price of $22.0 on 05/09/2025
- Salveen Richter from Goldman Sachs set a target price of $13.0 on 05/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
